**Author details**

Theodoros Ntoskas Department of Cardiology, Heart and Lung Centre, New Cross Hospital, Wolverhampton, United Kingdom

\*Address all correspondence to: theodoros.ntoskas@nhs.net

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**67**

*Cardio-Oncology: The Role of Echocardiography in Cancer Patients*

imaging evaluation of adult patients during and after cancer therapy: A report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Heart Journal. 2014;**27**(9):911-939. Available from: https://www.clinicalkey.es/ playcontent/1-s2.0-S0894731714005343

[7] Curigliano G, Cardinale D,

boris.unibe.ch/115250/

pubmed/29145954

S0735-1097(03)01065-9

[10] Douglas PS, Garcia MJ, Haines DE, Lai WW, Manning WJ, Patel AR, et al. ACCF/ASE/AHA/ASNC/HFSA/ HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography: A Report of the American College of Cardiology

[9] Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: Summary article: A report of the American college of cardiology/ American heart association task force on practice guidelines (ACC/AHA/ ASE committee to update the 1997 guidelines for the clinical application of Echocardiography). Circulation. 2003;**42**(5):954-970. DOI: 10.1016/

Suter T, Plataniotis G, De Azambuja E, Sandri MT, et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Annals of Oncology. 2012. Available from: https://

[8] Chang H-M, Moudgil R, Scarabelli T, Okwuosa TM, Yeh ETH. Cardiovascular complications of cancer therapy: Best practices in diagnosis, prevention, and management: Part 1. Journal of the American College of Cardiology. 2017;**70**(20):2536-2551. Available from: https://www.ncbi.nlm.nih.gov/

*DOI: http://dx.doi.org/10.5772/intechopen.93085*

[1] Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA: A Cancer Journal for Clinicians. 2012;**62**(4):220-241. DOI:

[2] Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S,

Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer. 2013;**49**(6):1374-1403. Available from: https://www.clinicalkey.es/ playcontent/1-s2.0-S0959804913000075

[3] Reulen RC, Winter DL, Frobisher C, Lancashire ER, Stiller CA, Jenney ME, et al. Long-term cause-specific mortality among survivors of childhood. Cancer. 2010;**304**(2):172-179. DOI: 10.1001/

[4] Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). European

Heart Journal. 2017;**19**(1):9-42. Available from: https://www.ncbi.nlm.

nih.gov/pubmed/27565769

[5] Khouri MG, Douglas PS, Mackey JR, Martin M, Scott JM, Scherrer-Crosbie M, et al. Cancer therapy-induced cardiac toxicity in early breast cancer: Addressing the unresolved issues. Circulation. 2012;**126**(23):2749-2763 Available from: https://www.ncbi.nlm.nih.gov/

[6] Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert consensus for multimodality

pubmed/23212997

**References**

10.3322/caac.21149

jama.2010.923

*Cardio-Oncology: The Role of Echocardiography in Cancer Patients DOI: http://dx.doi.org/10.5772/intechopen.93085*
